Priority 6 from the Idiopathic Intracranial Hypertension PSP

UNCERTAINTY: Can IIH biomarkers (tests in body fluids for example urine, saliva, blood, or brain scans) help diagnosis, predict the risk and guide therapy decisions in IIH? (JLA PSP Priority 6)
Overall ranking 6
JLA question ID 0066/6
Explanatory note Not available for this PSP
Evidence

None identified
Health Research Classification System category Neurological
Extra information provided by this PSP
Original uncertainty examples What are the prognostic markers for IIH? ~ How closely is weight correlated with risk of IIH (relapse) compared with other factors? ~ Are there any molecular mechanisms that can serve as potential targets for the development of novel therapies? ~ Why is it difficult to get a diagnosis of IIH?
Submitted by See data spreadsheet on JLA website
PSP information
PSP unique ID 0066
PSP name Idiopathic Intracranial Hypertension
Total number of uncertainties identified by this PSP. 48  (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop 27 April 2018